About Latigo Biotherapeutics
Latigo Biotherapeutics is a private company based in Thousand Oaks, California. It has reported $49,999,995 raised in one offering on Form D since February 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2025 | Feb 13, 2025 | $49,999,995of $149.9M target | 7 | $7.1M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Latigo Biotherapeutics's Form D filed Feb 13, 2025.
NS
Nancy Stagliano
Director
BS
Beth Seidenberg
Director
NF
Nima Farzan
Executive officer and director
JT
DP
Deborah Palestrant
Director
KR
Kevin Raidy
Director
TL
Tim Lugo
Chief Financial Officer
TW
Tim Walbert
Director